Skip to content

Bioequivalence study 3 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525450-11-00
Enrollment
40
Registered
2026-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's desease

Interventions

None listed

Sponsors

Orion Corporation
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 11, 2026